Equity

MARFX

Mid-Cap Value Fund

Overview

Loading

Performance

Performance

  YTD 1m 3m 1y 3y 5y 10y
-0.54 -3.22 -0.54 2.14 13.37 127.93 127.40
Benchmark (%) -2.11 -3.68 -2.11 2.27 11.78 116.47 108.33
Morningstar Category Avg. (%) -1.65 -3.37 -1.65 1.45 15.09 124.75 106.72
Lipper Category Avg. (%) -3.86 -4.49 -3.86 -0.71 13.04 113.08 106.60
  2020 2021 2022 2023 2024
Total Return (%) 7.18 26.34 -4.01 12.57 9.40
Benchmark (%) 4.96 28.34 -12.03 12.71 13.07
Morningstar Category Avg. (%) 2.63 29.32 -8.02 13.94 11.43

Performance is shown after deduction of ongoing charges. Any entry and exit charges are excluded from the calculation.

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance quoted.

The Fund’s returns prior to June 12, 2017 are the returns of the Fund when it followed different investment strategies under the name “BlackRock Mid Cap Value Opportunities Fund.” 
Click here for Distribution data

Key Facts

Key Facts

Size of Fund (Millions)
as of Apr 11, 2025
$845.5 M
Share Class launch date
Feb 01, 1995
Benchmark Index
Russell MidCap Value Index
Morningstar Category
Mid-Cap Value
CUSIP
09255V500
Open to New Investors
Yes
Size of Class (Millions)
as of Apr 11, 2025
$450.7 M
Asset Class
Equity
Distribution Frequency
Annual
Lipper Classification
Mid-Cap Value Funds
Max Offer Price
as of Apr 11, 2025
$20.76
Turnover Percent in the Annual Report
as of Apr 30, 2024
62.00%

Portfolio Characteristics

Portfolio Characteristics

Number of Holdings
as of Mar 31, 2025
111
P/E Ratio - Forward
as of Mar 31, 2025
13.17
Average Market Cap (Millions)
as of -
-
Fund Standard Deviation (3y)
as of Mar 31, 2025
17.67
Best 3-Month Return Over the Last 3 Years
3 months ending Jan 31, 2024
13.57%
Active Share
as of Mar 31, 2025
88.67%
P/B Ratio
as of Mar 31, 2025
1.64
Alpha (3y)
as of Mar 31, 2025
0.07
R-Squared (3y)
as of Mar 31, 2025
96.69
Beta (3y)
as of Mar 31, 2025
0.87
Worst 3-Month Return Over the Last 3 Years
3 months ending Jun 30, 2022
-12.06%

This information must be preceded or accompanied by a current prospectus. For standardized performance, please see the Performance section above.

Fees

Fees

as of current prospectus
Gross Expense Ratio 0.83%
Net Expense Ratio 0.75%

Net Expense Ratio excluding Investment Related Expenses is 0.74%

  • Acquired Fund Fees and Expenses 0.01%
  • Interest expense 0.00%

Ratings

Morningstar Rating

4 stars
Overall Morningstar Rating for Mid-Cap Value Fund, as of Mar 31, 2025 rated against 389 Mid-Cap Value Funds based on risk adjusted total return.

Morningstar Medalist Rating

Morningstar Medalist Rating - SILVER
Morningstar has awarded the Fund a Silver medal. (Effective Feb 28, 2025)
Analyst-Driven % as of Feb 28, 2025
55.00
Data Coverage % as of Feb 28, 2025
100.00

Lipper Leader

 
 
 
 
Overall Lipper Leaders ratings based on an equal-weighted average of percentile ranks for each measure over 3-, 5-, and 10-year periods (if applicable) and do not take into account the effects of sales charges for these categories (Consistent Return, Preservation, Total Return, Expense, and Tax Efficiency) as of Mar 31, 2025 out of 145, 12,247, 145, 82 and 144 Funds, respectively in Lipper's Mid-Cap Value Funds classification.

Holdings

Holdings

as of Mar 31, 2025
Name Weight (%)
CARDINAL HEALTH INC 2.95
SS&C TECHNOLOGIES HOLDINGS INC 2.76
FIRST CITIZENS BANCSHARES INC 2.60
CVS HEALTH CORP 2.53
BAXTER INTERNATIONAL INC 2.49
Name Weight (%)
L3HARRIS TECHNOLOGIES INC 2.10
FIDELITY NATIONAL INFORMATION SERVICES INC 2.00
LABCORP HOLDINGS INC 1.63
SEALED AIR CORPORATION 1.62
ELECTRONIC ARTS INC 1.59
Holdings are subject to change. Fund holdings and allocations shown are unaudited, and may not be representative of current or future investments. The Fund is actively managed and its details, holdings and characteristics will vary. Holdings shown should not be deemed as a recommendation to buy or sell securities. The user relies on this data at its own risk and neither BlackRock nor any other party makes any representations or express or implied warranties (which are expressly disclaimed) nor shall they incur any liability for any errors or omissions in the data.

Exposure Breakdowns

Exposure Breakdowns

as of Mar 31, 2025

% of Market Value

Show More
as of Mar 31, 2025

% of Market Value

Negative weightings may result from specific circumstances (including timing differences between trade and settle dates of securities purchased by the funds) and/or the use of certain financial instruments, including derivatives, which may be used to gain or reduce market exposure and/or risk management.

Allocations are subject to change.

Portfolio Managers

Portfolio Managers

Tony DeSpirito
Global CIO of Fundamental Equities, Portfolio Manager, Managing Director

   

David Zhao
Portfolio Manager, Managing Director

  

Portfolio Manager

Literature

Literature